A detailed history of Holos Integrated Wealth LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Holos Integrated Wealth LLC holds 831 shares of ABBV stock, worth $194,454. This represents 0.1% of its overall portfolio holdings.

Number of Shares
831
Previous 903 7.97%
Holding current value
$194,454
Previous $189 Million 13.1%
% of portfolio
0.1%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

SELL
$170.16 - $206.27 $12,251 - $14,851
-72 Reduced 7.97%
831 $164 Million
Q4 2024

Aug 08, 2025

BUY
$164.99 - $203.87 $148,985 - $184,094
903 New
903 $161 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Holos Integrated Wealth LLC Portfolio

Follow Holos Integrated Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holos Integrated Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Holos Integrated Wealth LLC with notifications on news.